In two ER-positive breast cancer cell lines, the nuclear ER expression was measured by staining with various ER MoAbs and compared with the ER transcriptional activity measured with the mRNA-based ER pathway activity assay developed in our lab. This evidence concerns the gene ESR1 and breast carcinoma.